{"id":20268,"date":"2014-04-24T13:29:47","date_gmt":"2014-04-24T17:29:47","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=20268"},"modified":"2014-04-24T13:43:20","modified_gmt":"2014-04-24T17:43:20","slug":"20268","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/20268-20268","title":{"rendered":"Zogenix, Inc. (NASDAQ:ZGNX) Sells SUMAVEL DosePro for $105 Million"},"content":{"rendered":"<p style=\"text-align: justify;\">Boston, MA 04\/24\/2014 (wallstreetpr) &#8211;\u00a0<b>Zogenix, Inc. (NASDAQ:ZGNX)<\/b> continues to surge in early morning trading after announcing it is selling its SUMAVEL DosePro Needle-free Delivery system for $105 million to Endo International Plc. The transaction will involve $85 million in cash and a milestone payment totaling $20 million.<\/p>\n<p style=\"text-align: justify;\">The sell will allow the company to have a greater level of focus on Zohydro and accord it enough capital to be used for the development of Zohydro ER while also advancing pipeline products in CNS disorders.\u00a0 Zogenix, Inc. (NASDAQ:ZGNX) CEO has stated the company will try to enhance development and building of pain business going forward.<\/p>\n<p style=\"text-align: justify;\">The agreement will allow SUMAVEL receive the much needed resources to reach more prescribers while also according the much needed help to migraine patients. Launched in January 2010, SUMAVEL DosePro has reached over 270,000 total prescriptions having distributed over 2 million units in 2013. Its net sales for 2013 clocked in at $31.7 million.<\/p>\n<p style=\"text-align: justify;\"><b>\u00a0Terms of the Sale<\/b><\/p>\n<p style=\"text-align: justify;\">Terns of sale involve Endo paying Zogenix $85 million in cash upon closure of the deal; a portion will be deposited to fund any indemnification claims for the next 12 months. Zogenix will also be eligible to receive an additional $20 million if SUMAVEL achieves predetermined sales and manufacturing milestones within the agreed time.<\/p>\n<p style=\"text-align: justify;\">\u00a0Zogenix, Inc. (NASDAQ:ZGNX) \u00a0is also entitled to continue manufacturing SUMAVEL DosePro under a supply agreement of which upon closure of the deal, Endo will purchase any finished goods and inventory as well as manufacturing operations.<\/p>\n<p style=\"text-align: justify;\">\u00a0The two companies expect the transaction to close in the second quarter of the year after satisfaction of closing conditions. Zogenix plans to use about $40 million of the acquisition fees to eliminate its debt obligation with HealthCare Royalty Partners. The remaining amount will be used to bolster the company\u2019s operating capital while also supporting commercial activities.<\/p>\n<p style=\"text-align: justify;\">\u00a0Endo will obtain worldwide rights of SUMAVEL DosePro new drug application with Zogenix maintaining ownership of DosePro Needle-Free Delivery system technology, as well as all manufacturing assets. Zogenix, Inc. (NASDAQ:ZGNX) plans to use the assets to leverage its technology in a wide range of product opportunities. Endo on the other hand will be entitled to Zogenix royalty obligation to Aradigm.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 04\/24\/2014 (wallstreetpr) &#8211;\u00a0Zogenix, Inc. (NASDAQ:ZGNX) continues to surge in early morning trading after announcing it is selling its SUMAVEL DosePro Needle-free Delivery system [&hellip;]<\/p>\n","protected":false},"author":32,"featured_media":14265,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[263],"tags":[3897,3896],"stock_ticker":[],"class_list":["post-20268","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-technology","tag-nasdaqzgnx","tag-zogenix-inc-nasdaqzgnx","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Zogenix, Inc. (NASDAQ:ZGNX) Sells SUMAVEL DosePro for $105 Million - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/20268-20268\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Zogenix, Inc. (NASDAQ:ZGNX) Sells SUMAVEL DosePro for $105 Million - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 04\/24\/2014 (wallstreetpr) &#8211;\u00a0Zogenix, Inc. (NASDAQ:ZGNX) continues to surge in early morning trading after announcing it is selling its SUMAVEL DosePro Needle-free Delivery system [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/20268-20268\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-04-24T17:29:47+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2014-04-24T17:43:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Zogenix-Inc.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"509\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Greg Folin\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Greg Folin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/20268-20268#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/20268-20268\"},\"author\":{\"name\":\"Greg Folin\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e\"},\"headline\":\"Zogenix, Inc. (NASDAQ:ZGNX) Sells SUMAVEL DosePro for $105 Million\",\"datePublished\":\"2014-04-24T17:29:47+00:00\",\"dateModified\":\"2014-04-24T17:43:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/20268-20268\"},\"wordCount\":369,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/20268-20268#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Zogenix-Inc.jpg\",\"keywords\":[\"NASDAQ:ZGNX\",\"Zogenix Inc. (NASDAQ:ZGNX)\"],\"articleSection\":[\"Technology\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/20268-20268#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/20268-20268\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/20268-20268\",\"name\":\"Zogenix, Inc. (NASDAQ:ZGNX) Sells SUMAVEL DosePro for $105 Million - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/20268-20268#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/20268-20268#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Zogenix-Inc.jpg\",\"datePublished\":\"2014-04-24T17:29:47+00:00\",\"dateModified\":\"2014-04-24T17:43:20+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/20268-20268#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/20268-20268\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/20268-20268#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Zogenix-Inc.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Zogenix-Inc.jpg\",\"width\":1024,\"height\":509},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/20268-20268#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Zogenix, Inc. (NASDAQ:ZGNX) Sells SUMAVEL DosePro for $105 Million\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e\",\"name\":\"Greg Folin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg\",\"caption\":\"Greg Folin\"},\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/greg-folin\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Zogenix, Inc. (NASDAQ:ZGNX) Sells SUMAVEL DosePro for $105 Million - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/20268-20268","og_locale":"en_US","og_type":"article","og_title":"Zogenix, Inc. (NASDAQ:ZGNX) Sells SUMAVEL DosePro for $105 Million - Wall Street PR","og_description":"Boston, MA 04\/24\/2014 (wallstreetpr) &#8211;\u00a0Zogenix, Inc. (NASDAQ:ZGNX) continues to surge in early morning trading after announcing it is selling its SUMAVEL DosePro Needle-free Delivery system [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/20268-20268","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2014-04-24T17:29:47+00:00","article_modified_time":"2014-04-24T17:43:20+00:00","og_image":[{"width":1024,"height":509,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Zogenix-Inc.jpg","type":"image\/jpeg"}],"author":"Greg Folin","twitter_misc":{"Written by":"Greg Folin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/20268-20268#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/20268-20268"},"author":{"name":"Greg Folin","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e"},"headline":"Zogenix, Inc. (NASDAQ:ZGNX) Sells SUMAVEL DosePro for $105 Million","datePublished":"2014-04-24T17:29:47+00:00","dateModified":"2014-04-24T17:43:20+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/20268-20268"},"wordCount":369,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/20268-20268#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Zogenix-Inc.jpg","keywords":["NASDAQ:ZGNX","Zogenix Inc. (NASDAQ:ZGNX)"],"articleSection":["Technology"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/20268-20268#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/20268-20268","url":"https:\/\/cablemanpro.com\/wallstreetpr\/20268-20268","name":"Zogenix, Inc. (NASDAQ:ZGNX) Sells SUMAVEL DosePro for $105 Million - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/20268-20268#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/20268-20268#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Zogenix-Inc.jpg","datePublished":"2014-04-24T17:29:47+00:00","dateModified":"2014-04-24T17:43:20+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/20268-20268#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/20268-20268"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/20268-20268#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Zogenix-Inc.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Zogenix-Inc.jpg","width":1024,"height":509},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/20268-20268#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Zogenix, Inc. (NASDAQ:ZGNX) Sells SUMAVEL DosePro for $105 Million"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e","name":"Greg Folin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg","caption":"Greg Folin"},"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/greg-folin"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/20268","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=20268"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/20268\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/14265"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=20268"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=20268"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=20268"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=20268"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}